$172.93-5.50 (-3.09%)
Align Technology, Inc.
Align Technology, Inc. in the Healthcare sector is trading at $172.93 with a market capitalization of $12.8B. Wall Street consensus targets $209.07 (14 analysts), implying a +20.9% move over the next 12 months. The stock is currently 17% below its 52-week high of $208.31, remaining 7.2% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.04B↓ | $1.05B↑ | $995.69M↓ | $1.01B↑ | $979.26M |
| Gross Profit | $736.59M↑ | $683.59M↑ | $639.20M↓ | $708.12M↑ | $680.11M |
| Operating Income | $172.59M↑ | $158.88M↑ | $128.13M↓ | $163.03M↑ | $135.28M |
| Net Income | $112.77M↓ | $135.76M↑ | $56.75M↓ | $124.61M↑ | $93.23M |
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package...
Over the past six months, Align Technology has been a great trade, beating the S&P 500 by 5.5%. Its stock price has climbed to $177.15, representing a healthy 12.2% increase. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Here is how Aveanna Healthcare (AVAH) and Align Technology (ALGN) have performed compared to their sector so far this year.
While Align Technology has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?